ClinConnect ClinConnect Logo
Search / Trial NCT06098911

Modified Atraumatic Restorative Treatment Using CPP ACP

Launched by CAIRO UNIVERSITY · Oct 22, 2023

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

Cpp Acp Atraumatic Restorative Treatment

ClinConnect Summary

This clinical trial is studying a new way to treat cavities in young children using a special substance called Casein Phosphopeptide Amorphous Calcium Phosphate (CPP-ACP) under a type of filling material known as glass ionomer. This approach aims to help repair teeth in a gentle way, especially for kids aged 4 to 7 who have mild to moderate cavities in their second primary molars (the back teeth). The goal is to see how well this treatment works both in pictures taken by X-rays and through clinical checks by dentists.

To participate in this trial, children must be healthy and not show any severe dental issues, like pain or serious gum problems. They should also have specific types of cavities that the study focuses on. The trial is not yet recruiting participants, but once it starts, selected children will receive the new treatment and will need to come back for follow-up visits to track their progress. It's important to know that children with certain health conditions, allergies, or those who might not cooperate during visits will not be eligible for the study. This trial represents a promising effort to improve dental care for young patients.

Gender

ALL

Eligibility criteria

  • * Inclusion Criteria:
  • Clinical Criteria:
  • Children aged 4-7 years. Apparently healthy children. Children with mild to moderate occlusal carious lesions in the mandibular second primary molar indicated for indirect pulp capping.
  • No history of spontaneous pain, pathologic mobility, draining sinus tract, redness or swelling of vestibule.
  • Normal gingival and periodontal condition, with no sensitivity to vestibular palpation, and no pain on percussion test.
  • Radiographic criteria:
  • No sign of radiolucency in periapical or furcation area.
  • No widening of PDL space or loss of lamina dura continuity.
  • No evidence of internal/external pathologic root resorption.
  • Exclusion Criteria:
  • Uncooperative children to avoid time waste and attrition bias.
  • Children with systemic disease as some systemic diseases may have effect on the outcome Children with known allergy to any of the components being utilized. Molars near exfoliation.
  • Primary molars with more than half of the root resorbed or with periapical pathology as evident radiographically Mobile or ankylosed molars with no permanent successors
  • Unable to attend follow-up visits to avoid attrition bias by decreasing number of drop off cases.
  • Refusal of participation as the parent of child has the authority of participation.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported